Select Publications
Journal articles
2023, 'The 'Starburst' Sign: A Novel Description of PET Images in Carcinoma of Unknown Primary', Anticancer Research, 43, pp. 4237 - 4239, http://dx.doi.org/10.21873/anticanres.16616
,2023, 'Outcomes for Colorectal Cancer Cases With Peritoneal Metastases Treated With Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A Comparative Analysis of Survival Between Peritoneal Carcinomatosis Scores - PCI in a Single Centre', Anticancer Research, 43, pp. 3529 - 3538, http://dx.doi.org/10.21873/anticanres.16530
,2023, 'Peritoneal metastasis of advanced epithelial ovarian carcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective international multicentric data analysis', European Journal of Surgical Oncology, 49, pp. 1489 - 1494, http://dx.doi.org/10.1016/j.ejso.2023.03.214
,2023, 'Overall survival and morbidity are not associated with advanced age for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A single centre experience', Pleura and Peritoneum, 8, pp. 83 - 90, http://dx.doi.org/10.1515/pp-2022-0202
,2023, 'Controversy Over Liver Transplantation or Resection for Neuroendocrine Liver Metastasis: Tumor Biology Cuts the Deal', Annals of Surgery, 277, pp. E1063 - E1071, http://dx.doi.org/10.1097/SLA.0000000000005663
,2023, 'Survival benefits with EPIC in addition to HIPEC for low grade appendiceal neoplasms with pseudomyxoma peritonei: A propensity score matched study', Pleura and Peritoneum, 8, pp. 27 - 35, http://dx.doi.org/10.1515/pp-2022-0205
,2023, 'Increased Incidence of Liver Metastases in Colorectal Versus Appendiceal Adenocarcinoma Peritonectomy Patients Despite Equivocal Survival', Anticancer Research, 43, pp. 4657 - 4662, http://dx.doi.org/10.21873/anticanres.16661
,2022, 'Second-look Surgery for Appendiceal High Grade and Colorectal Cancers following Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)', In Vivo, 36, pp. 2350 - 2356, http://dx.doi.org/10.21873/invivo.12966
,2022, 'Cytoreductive Surgery and HIPEC for Malignant Peritoneal Mesothelioma: Outcomes and Survival From an Australian Centre', Anticancer Research, 42, pp. 2939 - 2944, http://dx.doi.org/10.21873/anticanres.15776
,2022, 'Case series on high grade appendiceal cancer with peritoneal and liver carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)', International Journal of Surgery Case Reports, 94, http://dx.doi.org/10.1016/j.ijscr.2022.107027
,2022, 'Cost-effectiveness of Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis', In Vivo, 36, pp. 1527 - 1533, http://dx.doi.org/10.21873/invivo.12863
,2022, 'Impact pronostic de la proportion de cellules en bague-à-chaton chez les patients atteints de cancers colorectaux avec métastases péritonéales', Journal de Chirurgie Viscérale, 159, pp. S73 - S73, http://dx.doi.org/10.1016/j.jchirv.2022.07.018
,2021, 'The 5 Year Outcomes of Early Postoperative Intra-Peritoneal Chemotherapy (EPIC) in High-Grade Appendiceal Cancer – Does regimen length and cancer subtype make a difference?', Surgical Research, 3, http://dx.doi.org/10.33425/2689-1093.1038
,2021, 'Risk factors and clinical outcomes in patients undergoing cytoreductive surgery with concomitant ureteric reimplantation', Pleura and Peritoneum, 6, pp. 155 - 160, http://dx.doi.org/10.1515/pp-2021-0130
,2021, 'Peritoneal spread of low-grade appendiceal tumours - 2 days of early postoperative intra-peritoneal chemotherapy are enough', Anticancer Research, 41, pp. 5569 - 5575, http://dx.doi.org/10.21873/anticanres.15370
,2021, 'Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumours treated by cytoreductive surgery: Study protocol of a prospective, multicentre, observational study', BMJ Open, 11, http://dx.doi.org/10.1136/bmjopen-2020-046819
,